Global Pessary Market, by type (Gellhorn, Ring, Donut and others), by Products (Mild Pelvic Organ Prolapse, Stress Urinary Incontinence, Severe Pelvic Organ Prolapse), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics)– Industry Trends and Forecast to 2029.
Market Analysis and Size
In recent years, the vaginal pessary market has had exceptional growth, which is expected to continue in the following years. Increased investments in R&D, the entry of new companies, product innovation, technological breakthroughs, efficient resource allocation, and greater competitiveness among business rivals could all contribute to the vaginal pessary sector's expansion.
Data Bridge Market Research analyses that the pessary market was valued at USD 294.7 million in 2021, would rocket up to USD 568.09 million by 2029, and is expected to undergo a CAGR of 8.55% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Pessary is a vaginal device implanted to support sagging organs that have prolapsed or stopped urine flow. Pelvic organ prolapse (POP) is treated using vaginal mesh, a medical device. It can be inserted to help strengthen the vaginal wall that has become weakened.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By type (Gellhorn, Ring, Donut and others), By Products (Mild Pelvic Organ Prolapse,Stress Urinary Incontinence,Severe Pelvic Organ Prolapse),By End-use (Hospitals, Ambulatory Surgical Centers, Clinics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Personal Medical Corp (U.S), Integra LifeSciences (U.S), PanpacMedical (China), Medesign India (India), SmithsMedical (U.S), St Thomas Medical Group (U.S), MedGyn Products, Inc. (U.S.), Cooper Surgical Inc. (U.S), Medical Consulting Group, LLC (U.S.), Bioteque America, Inc. (U.S.), Dr. Arabin GmbH & Co. (Germany), Wallach Surgical Devices (U.S.), MEDESIGN INDIA (India), Kangge Medical (China)
|
|
Market Opportunities
|
|
Pessary Market Dynamics
Drivers
- Delay Surgery
Surgery is an option many women would prefer to avoid, and pessaries can help women postpone or prevent surgical procedures. It reduces the danger of surgery for women who are physically unable to undergo it.
- Variety
Ring pessaries, Gehrung pessaries, and shelf pessaries are only a few of the many types of pessaries available. There are several choices to choose from depending on the degree and type of symptoms.
- Growing geriatric population
The high success rate of pessaries will propel the pessary sector to new heights. Furthermore, disorders linked to one's way of life are on the rise. The rising prevalence of diseases such as pelvic organ prolapse and urine incontinence would support the pessary market's growth.
- Inclusion of Pessaries in Insurance Policies
Pessaries were rarely covered by insurance coverage. Pessaries are now covered by insurance policies, thanks to increased knowledge and increased use of pessaries. Based on these factors, the pessary market is predicted to rise quickly.
Opportunities
Vaginal pessaries are one of the most popular treatments for organ prolapse and incontinence because they are easy to use, inexpensive, and safe. Compared to other treatment alternatives, these variables contribute to a higher patient satisfaction rate. As a result, vaginal pessaries are now commonly used to treat pelvic prolapse and/or stress urinary incontinence. Women of all ages are affected by Pelvic Organ Prolapse (POP). In the near future, positive government policies and incentives and favorable regulations are expected to determine the growth of the vaginal pessary market. Customers' spending capacity will expand as their disposable income rises, which will help the vaginal pessary industry grow even more.
Restraints/Challenges
- Not suitable for all women
Many women have physical issues that prevent them from using a pessary in the first place. Women with lichen sclerosis cannot use pessaries to address their prolapse symptoms. Women who had a hysterectomy and have prolapse have trouble keeping the pessary inside the body.
- Must be replaced frequently
Because pessaries are prone to be dislodged or causing internal pain, it may be necessary to visit the doctor several times to have one fitted. Because pessaries come in various shapes and sizes, some women may need to experiment with numerous styles to discover one that best suits them.
- Difficulty with sexual intercourse
Pessaries have been reported to induce discomfort during sexual intercourse by patients. Some women opt to remove them first, which can be inconvenient depending on the pessary used. In order to maintain both a pessary and a healthy sex life, a significant amount of self-maintenance is required.
This pessary market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pessary market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Pessary Market
The COVID-19 epidemic has wreaked havoc on economic and social institutions around the world. The disease has infiltrated the value and supply chains of various businesses, including the vaginal pessary market. Lockdowns were imposed by the government in a number of sites. We'll look at both demand and supply to see how the COVID-19 epidemic has affected the global market.
To summarize, the short- and long-term effects of the COVID-19 pandemic will be investigated. During and after the pandemic, this would aid in the development of business plans for all market participants, including manufacturers, vendors, suppliers, distributors, and end-users.
Recent Development
• In May 2021, the noninferiority of 25 μg misoprostol every four hours to the dinoprostone pessary for caesarean delivery (CD) rates after induction of labor (IOL) at term could not be demonstrated, even though the confidence limit of the difference barely exceeded the noninferiority margin, according to the findings of the study.
Global Pessary Market Scope
The pessary market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Gellhorn
- Ring
- Donut
- Others
Application
- Mild Pelvic Organ Prolapse
- Stress Urinary Incontinence
- Severe Pelvic Organ Prolapse
End-use
- Hospitals
- Ambulatory Surgical Centres
- Clinics
Pessary Market Regional Analysis/Insights
The pessary market is analyzed and market size insights and trends are provided by country, type, application and end-user as referenced above.
The countries covered in the pessary market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominated the market in 2020, accounting for 41.1 percent of total sales. Due to factors such as an older female population, lifestyle changes that create hormonal disturbances, the rising prevalence of pelvic organ prolapse, and improved health awareness. According to the US Department of Health and Human Services, 3.3 million women in the United States have experienced pelvic organ prolapse, with that figure anticipated to climb to 4.9 million by 2050 as a result of a possible link with ageing.
Over the forecast period, the market for pessary in Asia Pacific is expected to develop exponentially. Emerging economies, an older population, and improved healthcare awareness are likely to drive the fastest growth rate in the regional market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The pessary market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pessary market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pessary market. The data is available for historic period 2010-2020.
Competitive Landscape and Pessary Market Share Analysis
The pessary market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pessary market.
Some of the major players operating in the pessary market are:
- Personal Medical Corp (U.S)
- Integra LifeSciences (U.S)
- PanpacMedical (China)
- Medesign India (India)
- SmithsMedical (U.S)
- St Thomas Medical Group (U.S)
- MedGyn Products, Inc. (U.S)
- Cooper Surgical Inc. (U.S)
- Medical Consulting Group, LLC (U.S.)
- Bioteque America, Inc. (U.S.)
- Dr. Arabin GmbH & Co. (Germany)
- Wallach Surgical Devices (U.S.)
- MEDESIGN INDIA (India)
- Kangge Medical (China)
SKU-